Caring Brands, Inc. logo

Caring Brands, Inc.

CABR

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

Latest quote

$1.35

+$0.06 · +4.65%

Aug 24, 12:00 PM ETData delayed

CABR company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

28

Expensive

Momentum

67

Gaining

Sentiment

49

Mixed

Risk resilience

50

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Caring Brands, Inc. operates as a consumer wellness company, offering a varied collection of over-the-counter (OTC) and cosmetic merchandise. Its extensive product catalog features items such as hair loss treatments, solutions for eczema and psoriasis, vitiligo remedies, a specialized sun protection line that defends against jellyfish stings, and intimate health products for women. All these offerings are crafted to fulfill a wide array of health and personal care requirements. The firm was founded in 2020 and is based in Jupiter, Florida.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
US
CEO
Glynn Wilson
Listed since
Jun 17, 2025
Employees
3

Market position

Volume
3.57K
0.04× average
Average volume
81.01K
Average daily volume
Market cap
12.27M USD
Beta
-0.63
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
9.51M USD
P/E (TTM)
-2.16×
P/B (TTM)
5.62×
P/S (TTM)
10,580.63×
EV / EBITDA
-1.79×
Earnings yield
-53.95%
Free cash flow yield
-14.54%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
59.22%
Operating margin
-556689.48%
Net margin
-610975.17%
Return on equity
-300.20%
Return on assets
-269.82%
Return on invested capital
-276.05%

Financial health

Debt / equity
Current ratio
13.16×

Financial statements

Metric (USD)FY2025
Revenue4.22K USD
Cost of goods sold1.87K USD
Gross profit2.34K USD
Selling, general, and administrative3.09M USD
Operating expenses5.94M USD
Interest expense19.17K USD
Depreciation and amortization300K USD
Operating income−5.94M USD
Net income−6.28M USD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-0.1

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates-0.08-0.17-0.25-0.33Q1 '26Q2 '26Q3 '26
Q1 2026, reported Mar 31, 2026: actual -0.29, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 12, 2026: actual -0.27, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 13, 2026: actual -0.1, estimate —, surprise —, Comparison unavailable.

CABR peers

ETFs holding CABR

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research CABR

research.disclaimer